Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis

FASEB Journal

Volumn 24, Issue 12, 2010, Pages 4678-4690

  Iizuka, Yoshiko ^a   Okuno, Toshiaki ^c   Saeki, Kazuko ^c   Uozaki, Hiroshi ^a   Okada, Shinji ^b   Misaka, Takumi ^b   Sato, Tetsuya ^d   Toh, Hiroyuki ^d   Fukayama, Masashi ^a   Takeda, Naoki ^f   Kita, Yoshihiro ^a   Shimizu, Takao ^a   Nakamura, Motonao ^a   Yokomizo, Takehiko ^a,c,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Arachidonic cascade; Eicosanoids; G protein coupled receptor; Inflammatory bowel diseases

Indexed keywords

BLT2 PROTEIN; CHEMOKINE; CXCL9 CHEMOKINE; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE B4 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT REDUCTION;

ANIMALS; CELL LINE; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DOGS; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINAL MUCOSA; MACROPHAGES; MALE; MICE; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LEUKOTRIENE B4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MURINAE; MUS;

EID: 78649726409     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-165050     Document Type: Article

References (41)

1. Luster, A. D., and Tager, A. M. (2004) T-Cell trafficking in asthma: Lipid mediators grease the way. Nat. Rev. Immunol. 4, 711-724
2. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624
3. Kamohara, M., Takasaki, J., Matsumoto, M., Saito, T., Ohishi, T., Ishii, H., and Furuichi, K. (2000) Molecular cloning and characterization of another leukotriene B4 receptor. J. Biol. Chem. 275, 27000-27004
4. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., and Shimizu, T. (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421-432
5. Toda, A., Terawaki, K., Yamazaki, S., Saeki, K., Shimizu, T., and Yokomizo, T. (2010) Attenuated Th1 induction by dendritic cells from mice deficient in the leukotriene B4 receptor 1. Biochimie (Paris) 92, 682-691
6. Terawaki, K., Yokomizo, T., Nagase, T., Toda, A., Taniguchi, M., Hashizume, K., Yagi, T., and Shimizu, T. (2005) Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175, 4217-4225
7. Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D., and von Andrian, U. H. (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4, 965-973
8. Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., Carafone, A. D., Gerszten, R. E., and Luster, A. D. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4, 982-990
9. Yokomizo, T., Kato, K., Hagiya, H., Izumi, T., and Shimizu, T. (2001) Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276, 12454-12459
10. Okuno, T., Iizuka, Y., Okazaki, H., Yokomizo, T., Taguchi, R., and Shimizu, T. (2008) 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. J. Exp. Med. 205, 759-766
11. Yoo, M. H., Song, H., Woo, C. H., Kim, H., and Kim, J. H. (2004) Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 23, 9259-9268
12. Hennig, R., Osman, T., Esposito, I., Giese, N., Rao, S. M., Ding, X. Z., Tong, W. G., Buchler, M. W., Yokomizo, T., Friess, H., and Adrian, T. E. (2008) BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer 99, 1064-1073
13. Shao, W. H., Del Prete, A., Bock, C. B., and Haribabu, B. (2006) Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J. Immunol. 176, 6254-6261
14. Cho, K. J., Seo, J. M., Shin, Y., Yoo, M. H., Park, C. S., Lee, S. H., Chang, Y. S., Cho, S. H., and Kim, J. H. (2010) Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor. Am. J. Respir. Cell Mol. Biol. 42, 294-303
15. Kim, G. Y., Lee, J. W., Cho, S. H., Seo, J. M., and Kim, J. H. (2009) Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 915-920
16. Iizuka, Y., Yokomizo, T., Terawaki, K., Komine, M., Tamaki, K., and Shimizu, T. (2005) Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J. Biol. Chem. 280, 24816-24823
17. Yagi, T., Tokunaga, T., Furuta, Y., Nada, S., Yoshida, M., Tsukada, T., Saga, Y., Takeda, N., Ikawa, Y., and Aizawa, S. (1993) A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214, 70-76
18. Lin, A. H., Ruppel, P. L., and Gorman, R. R. (1984) Leukotriene B4 binding to human neutrophils. Prostaglandins 28, 837-849
19. Cooper, H. S., Murthy, S. N., Shah, R. S., and Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249
20. Du, P., Kibbe, W. A., and Lin, S. M. (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548
21. Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199
22. Okuno, T., Ago, H., Terawaki, K., Miyano, M., Shimizu, T., and Yokomizo, T. (2003) Helix 8 of the leukotriene B-4 receptor is required for the conformational change to the low affinity state after G-protein activation. J. Biol. Chem. 278, 41500-41509
23. Kato, K., Yokomizo, T., Izumi, T., and Shimizu, T. (2000) Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene. J. Exp. Med. 192, 413-420
24. Inohara, N., Koseki, T., Chen, S., Wu, X., and Nunez, G. (1998) CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 17, 2526-2533
25. Gertner, D. J., Rampton, D. S., Madden, M. V., Talbot, I. C., Nicholls, R. J., and Lennard-Jones, J. E. (1994) Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. Gut 35, 1429-1432
26. Lauritsen, K., Laursen, L. S., Bukhave, K., and Rask-Madsen, J. (1986) Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91, 837-844
27. Bouchelouche, P. N., Berild, D., Nielsen, O. H., Elmgreen, J., and Poulsen, H. S. (1995) Leukotriene B4 receptor levels and intracellular calcium signalling in polymorphonuclear leukocytes from patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 7, 349-356
28. Fretland, D. J., Anglin, C. P., Widomski, D., Baron, D. A., Maziasz, T., and Smith, P. F. (1995) Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents. Inflammation 19, 503-515
29. Fretland, D. J., Widomski, D., Tsai, B. S., Zemaitis, J. M., Levin, S., Djuric, S. W., Shone, R. L., and Gaginella, T. S. (1990) Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit. J. Pharmacol. Exp. Ther. 255, 572-576
30. Fretland, D. J., Levin, S., Tsai, B. S., Djuric, S. W., Widomski, D. L., Zemaitis, J. M., Shone, R. L., and Bauer, R. F. (1989) The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation. Agents Actions 27, 395-397
31. Kita, Y., Takahashi, T., Uozumi, N., and Shimizu, T. (2005) A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Biochem. 342, 134-143
32. Rigby, R. J., Simmons, J. G., Greenhalgh, C. J., Alexander, W. S., and Lund, P. K. (2007) Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene 26, 4833-4841
33. Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K., Akira, S., Matsumoto, S., Toyonaga, A., Sata, M., and Yoshimura, A. (2001) CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193, 471-481
34. Abraham, C., and Cho, J. H. (2009) Mechanisms of disease inflammatory bowel disease. N. Engl. J. Med. 361, 2066-2078
35. Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., Ouwehand, W. H., Samani, N. J., Todd, J. A., Donnelly, P., Barrett, J. C., Davison, D., Easton, D., Evans, D., Leung, H. T., Marchini, J. L., Morris, A. P., Spencer, C. C. A., Tobin, M. D., Attwood, A. P., Boorman, J. P., Cant, B., Everson, U., Hussey, J. M., Jolley, J. D., Knight, A. S., Koch, K., Meech, E., Nutland, S., Prowse, C. V., Stevens, H. E., Taylor, N. C., Walters, G. R., Walker, N. M., Watkins, N. A., Winzer, T., Jones, R. W., McArdle, W. L., Ring, S. M., Strachan, D. P., Pembrey, M., Breen, G., St Clair, D., Caesar, S., Gordon-Smith, K., Jones, L., Fraser, C., Green, E. K., Grozeva, D., Hamshere, M. L., Holmans, P. A., Jones, I. R., Kirov, G., Moskvina, V., Nikolov, I., O'Donovan, M. C., Owen, M. J., Collier, D. A., Elkin, A., Farmer, A., Williamson, R., McGuffin, P., Young, A. H., Ferrier, I. N., Ball, S. G., Balmforth, A. J., Barrett, J. H., Bishop, D. T., Iles, M. M., Maqbool, A., Yuldasheva, N., Hall, A. S., Braund, P. S., Dixon, R. J., Mangino, M., Stevens, S., Thompson, J. R., Bredin, F., Tremelling, M., Parkes, M., Drummond, H., Lees, C. W., Nimmo, E. R., Satsangi, J., Fisher, S. A., Forbes, A., Lewis, C. M., Onnie, C. M., Prescott, N. J., Sanderson, J., Mathew, C. G., Barbour, J., Mohiuddin, M. K., Todhunter, C. E., Mansfield, J. C., Ahmad, T., Cummings, F. R., Jewell, D. P., Webster, J., Brown, M. J., Lathrop, G. M., Connell, J., Dominiczak, A., Marcano, C. A. B., Burke, B., Dobson, R., Gungadoo, J., Lee, K. L., Munroe, P. B., Newhouse, S. J., Onipinla, A., Wallace, C., Xue, M. Z., Caulfield, M., Farrall, M., Barton, A., Bruce, I. N., Donovan, H., Eyre, S., Gilbert, P. D., Hider, S. L., Hinks, A. M., John, S. L., Potter, C., Silman, A. J., Symmons, D. P. M., Thomson, W., Worthington, J., Dunger, D. B., Widmer, B., Frayling, T. M., Freathy, R. M., Lango, H., Perry, J. R. B., Shields, B. M., Weedon, M. N., Hattersley, A. T., Elliott, K. S., Groves, C. J., Lindgren, C. M., Rayner, N. W., Timpson, N. J., Zeggini, E., Newport, M., Sirugo, G., Lyons, E., Vannberg, F., Brown, M. A., Franklyn, J. A., Heward, J. M., Simmonds, M. J., Hill, A. V. S., Bradbury, L. A., Farrar, C., Pointon, J. J., Wordsmith, P., Gough, S. C. L., Seal, S., Stratton, M. R., Rahman, N., Ban, M., Goris, A., Sawcer, S. J., Compston, A., Conway, D., Jallow, M., Bumpstead, S. J., Chaney, A., Downes, K., Ghori, M. J. R., Gwilliam, R., Inouye, M., Keniry, A., King, E., McGinnis, R., Potter, S., Ravindrarajah, R., Whittaker, P., Withers, D., Easton, D., Pereira-Gale, J., Hallgrimsdottir, I. B., Howie, B. N., Su, Z., Teo, Y. Y., Vukcevic, D., Bentley, D., Caulfield, M., Mathew, C. G., and Worthington, J. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678
36. Chiang, N., Serhan, C. N., Dahlen, S. E., Drazen, J. M., Hay, D. W., Rovati, G. E., Shimizu, T., Yokomizo, T., and Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487
37. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722
38. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., and Serhan, C. N. (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U. S. A. 102, 7671-7676
39. Morteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., and Sartor, R. B. (2000) Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105, 469-478
40. Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., Ichikawa, A., and Narumiya, S. (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883-893
41. Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., Demarche, B., Gut, I., Heath, S., Foglio, M., Liang, L. M., Laukens, D., Mni, M., Zelenika, D., Van Gossum, A., Rutgeerts, P., Belaiche, J., Lathrop, M., and Georges, M. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58